CLINICAL_TRIALS
withdrawal
· 2021-11-26
Clinical Trial Update: A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks [Phase 4]
Summary
A Phase 4 clinical trial investigating greater occipital nerve block for acute migraine attacks has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Thomas Jefferson University | Conditions: Migraine | Phase 4 | Status: WITHDRAWN